Healthy adult
Conditions
Interventions
Lactoferrin (900 mg/d) for 2 weeks
Placebo for 2 weeks
Sponsors
Juntendo University, Graduate School of Health & Sports Science
Morinaga &
Co., Ltd (Tokyo, Japan)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) A healthy male university rugby player 2) Subjects who have given voluntary, written, informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1) Subjects receiving treatment (medicine prescription by a doctor) 2) Subjects suffering from serious cardiovascular disorder, liver function disorder, renal dysfunction, respiratory disorder, endocrine disorder, metabolic disorder, or those having history of them 3) Subjects with history of chest pain or fainting. 4) Subjects who are likely to cause allergies related to the test supplement 5) Subjects who donated 200 mL within 1 month prior to the start of the study, or 400 mL (blood donation etc.) within 3 months 6) Subjects who habitually takes lactoferrin 7) Smokers 8) Subjects who has seasonal allergic disease (cedar, Japanese cypress, etc.) 9) Subjects who have participated in other clinical trials within the past 3 months or who are currently participating in other clinical trials 10) Subjects who are judged as unsuitable for this study by physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fecal microbiota (Pre, 1 wk, 2wk) | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma metabolome, Responses of autonomic nerves system and salivary stress markers to calculation task | — |
Countries
Japan
Contacts
Public ContactYoshio Suzuki
Juntendo University Graduate School of Health and Sports Science
Outcome results
None listed